Home News Team Research Publications Positions Contact
School of Pharmacy · Sungkyunkwan University

Mapping how tumors evolve — one genome at a time.

We study extrachromosomal DNA, tumor evolution and intratumoral heterogeneity through large-scale computational and statistical analysis of cancer genomes.

29Cancer types surveyed
15Current lab members
2021Lab founded at SKKU
Lab life

Recent News

All news →
PaperAug 5, 2026

"Extrachromosomal DNA in cancer: mechanics, functions, and therapeutic implications"

A new review by Boyoon Kim, published in Signal Transduction and Targeted Therapy, exploring the mechanics, functions, and therapeutic implications of ecDNA.

PaperAug 1, 2026

Single-cell resolution tracking of oncogenic ecDNA inheritance

Co-authored by Eunchae, published in Experimental & Molecular Medicine — novel insight into ecDNA dynamics via single-cell analysis.

AwardJul 31, 2026

Boyoon Kim wins the Grand Prize at SKKU Research Matters Plus

Honored with the Grand Prize (대상) at the 1st Graduate Research Achievement Competition+ for her outstanding research contribution.

ScholarshipJul 21, 2026

Hyunjeong awarded the KOSAF Doctoral Excellence Scholarship

Selected for the Doctoral Excellence Scholarship in Science and Engineering from the Korea Student Aid Foundation.

Lab EventApr 27, 2026

Boyoon Kim presents at AACR 2026 — a lab milestone

Our first lab member to present at the AACR Annual Meeting, San Diego, drawing strong interest from academia and industry.

AwardMar 26, 2026

Boyoon Kim receives the KOBRA Travel Award

The Global-TA award supported her participation and presentation at AACR 2026.

PaperMar 26, 2026

Tailorable porous collagen hydrogels for ecDNA research

Co-first authored by Jiwon Shon, published in Theranostics — a 3D hydrogel platform that preserves ecDNA structures.

Lab EventMar 17, 2026

ecDNA foundation model proposal selected by NVIDIA

Selected for the NVIDIA Academic Grant Program with Prof. Se-Young Chun (SNU) — 32,000 A100 GPU-hours awarded.

PaperFeb 2, 2026

IDH-mutant gliomas arise from glial progenitor cells

Published in Science — identifying glial progenitor cells as the cell of origin in IDH-mutant gliomas.

ScholarshipSep 1, 2025

Yoonjoo awarded a National Research Foundation doctoral research grant

Funds her PhD research into how ecDNA interacts with micronuclei as tumors acquire chemotherapy resistance.

ScholarshipSep 1, 2025

Jueon awarded a National Research Foundation master's research grant

Supports her single-cell multi-omics study of ecDNA in glioblastoma.

Lab EventJun 23, 2025

Prof. Kim invited to present at ICBTRT 2025, Japan

Presented our longitudinal characterization of ecDNA amplifications in adult glioma at the 24th International Conference on Brain Tumor Research and Therapy.

What we study

Research

Full research page →
Illustration of extrachromosomal DNA (ecDNA) alongside chromosomal DNA inside a cancer cell nucleus Diagram of ecDNA prevalence changing from primary to advanced cancer across cancer types
What ecDNA is, and where it takes hold as cancer advances — Kim et al., Nature Genetics, 2024

“Our lab is all about big data.”

A major cause of cancer treatment failure is the development of therapy resistance in tumors, which evolve by accumulating tumor-promoting mutations and modified chromosome structures. Our lab addresses this through computational and statistical analysis of large-scale biomolecular data — centered on extrachromosomal DNA (ecDNA), work spanning long- and short-read sequencing, single-cell and spatial multiomics, FISH validation, and structural variant analysis, alongside collaborators across cancer biology, epigenetics, structural biology, bioimaging, and tumor microenvironment research.

Extrachromosomal DNA Multiomics Long- & short-read sequencing Structural variation Spatial genomics Tumor evolution Glioma biology Tumor microenvironment models
Single-cell tracking of oncogenic ecDNA inheritance and structural variation

ecDNA: Mechanics, Functions & Therapeutic Implications

Our most comprehensive synthesis to date on ecDNA's mechanical properties, biological functions, and therapeutic angles — building on our pan-cancer survey finding circular ecDNA in over 25 of 29 cancer types and our latest single-cell tracking of ecDNA inheritance.

Read more →
IDH-mutant glioma arising from glial progenitor cells

Tumor Evolution & Glioma Origin

From non-chromosomal ecDNA amplification driving intratumor heterogeneity to tracing IDH-mutant glioma back to the glial progenitor cells that first carry the driver mutation — with the GLASS consortium we co-founded.

Read more →
Tailorable porous collagen hydrogel platform for ecDNA research

ecDNA Across Cancer Types & New Research Platforms

Mapping ecDNA in gastric and breast cancer and Barrett's esophagus, and building tailorable 3D collagen hydrogel platforms that better preserve ecDNA structures for long-term study.

Read more →
Computational cancer genomics illustration

Computational Tools for Amplicon & SV Analysis

We co-developed AmpliconSuite, an end-to-end workflow now used broadly across the field for detecting and reconstructing focal amplifications — including ecDNA — from sequencing data.

Read more →
We're hiring

Open Positions

Hoon Lab recruitment notice for Computational Biomedicine positions

Interested in joining us? Reach out with your CV and a line about what draws you to computational cancer genomics — we'd love to hear from you.

Email the lab

Collaborators & support

Sungkyunkwan University The Jackson Laboratory GLASS Consortium NVIDIA Academic Grant Program Korea Student Aid Foundation MD Anderson Cancer Center